← Eichor
Study identifier: NCT07346976 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Investigation Into the Dynamic Variations of End-Tidal Carbon Monoxide Concentration (ETCOc) in Neonates Utilizing Non-Dispersive Infrared Spectroscopy and Its Implications for Jaundice Management

Condition: Neonatal Hyperbilirubinemia  ·  Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine

PhaseNA
Planned participants100
Who can joinAll sexes, 0 Days to 28 Days
Healthy volunteersYes

About this study

The objective of this study is to ascertain the diagnostic threshold of end-tidal carbon monoxide (ETCOc, adjusted for ambient CO levels) within the first three days postpartum, stratified by neonatal age at birth. Additionally, the study aims to evaluate the concordance of the risk range of ETCOc, as measured by non-dispersive infrared spectroscopy, with existing literature, and to assess the reliability of this technology in the management of neonatal hyperbilirubinemia.

This description comes directly from the study's public registry record.

Talk to the study team

Yixiang Wu  ·  +8613600643385  ·  laibujilene@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

4th Affiliated Hospital, School of Medicine, Zhejiang UniversityYiwu, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07346976